Research Article
Mutation Profile Assessed by Next-Generation Sequencing (NGS) of Circulating Tumor DNA (ctDNA) in Chinese Lung Adenocarcinoma Patients: Analysis of Real-World Data
Figure 2
Overall survival (OS) in the presence of exclusively EGFR mutation cases compared to coexisting mutations with EGFR patients: vs. 16.0 months, .